Key points
-
Pneumomediastinum requires exclusion of tracheobronchial injury.
-
Mediastinal post-operative changes are indistinguishable from acute mediastinitis during the first weeks following surgery.
-
CT, 18F-FDG PET/CT, and diffusion-weighted or dynamic contrast-enhanced MRI may help to narrow the differential diagnosis and may guide tissue sampling.
Background and technical approach
Clinical scenarios
Pneumomediastinum
Pathophysiology
Iatrogenic causes
Boerhaave’s syndrome
Tracheobronchial lesions
Other conditions
Acute mediastinitis
Pathophysiology
Imaging findings
Fibrosing mediastinitis and mimickers (Table 1)
Pathophysiology
Clinical scenarios | DIAGNOSIS | DIFFERENTIAL DIAGNOSIS | ||||||
---|---|---|---|---|---|---|---|---|
Fibrosing mediastinitis | Lymphoma | Castleman disease | Sarcoidosis | |||||
Granulomatous subtype | Nongranulomatous subtype | Erdheim-Chester | IgG-4 | |||||
IMAGING FEATURES OF FIBROSING MEDIASTINITIS AND DIFFERENTIAL DIAGNOSIS | X-ray Features | Focal calcified paratracheal, subcarinal or hilar mass ++ Widening of the mediastinum Distortion and obliteration of lines | Mediastinal widening Retrosternal filling Hilar enlargement | Mediastinal masses Displacement of adjacent structures Ipsilateral pleural effusion Periostal reaction | Mediastinal widening Mass effect Hilar lymphadenopathies Nodal and lung calcifications Reticulonodular opacities, lung fibrosis, traction bronchiectasis | |||
CT Features | Focal calcified paratracheal, subcarinal or hilar mass ++ Superior vena cava syndrome | Infiltrating soft tissue, rarely calcified Variable heterogeneous enhancement Pulmonary arterial hypertension and bronchial arteries hypertrophy Unilateral pulmonary oedema, lung volume loss, chronic post-obstructive pneumonitis, bronchiectasis | Periaortic infiltration extending to the pericardium, right coronary sulci and/or myocardium of the right atrium with pleural involvement Thickening of the peribronchovascular bundles and interlobular septae | Diffuse mass in the posterior mediastinum | Superior vena cava syndrome Lymphadenopathies, including internal mammary, axillary Pericardial, pleural (unilateral) effusion Calcification (post-treatment) Pulmonary nodule, mass-like consolidation, infiltrates | Solitary or multicentric infiltrative mediastinal mass, arborising calcifications Intense homogeneous enhancement and washout Lymph nodes Centrilobular nodules | Lymphadenopathies Perilymphatic nodules, micronodules of upper/mid lung distribution, lung fibrosis | |
MR Features | Heterogeneous T1 signal isointense to muscle Variable T2 signal Heterogeneous enhancement post-Gadolinium injection | Iso to hyperintense T1 relative to skeletal muscle Arborising calcifications as low T2 Enhancement post-Gadolinium injection Low ADC values | ||||||
CLINICAL AND IMAGING FEATURES OF EXTRA-THORACIC MANIFESTATIONS | Clinical Features | Superior vena cava syndrome | Non specific | Non specific | Riedel’s thyroiditis Retroperitoneal fibrosis Sclerosing cholangitis Autoimmune pancreatitis | +/- Palpable lymphadenopathies +/- Hepatosplenomegaly | Fluid retention | 50% asymptomatic Dry eyes Erythema nodosum Parotid enlargement |
Imaging Features | +/- retroperitoneal fibrosis | Bone pain Focal neurological involvement Exophthalmos Retroperitoneal fibrosis Hypophysal changes related to diabetes insipidus | CNS involvement Orbital pseudotumor Riedel thyroiditis Retroperitoneal fibrosis Autoimmune pancreatitis Sclerosing cholangitis |